Analyst Ratings for Ascendis Pharma (ASND)

ASND Rating Summary

ASND Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ASND
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $188.22 (+66.1%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/30/2021 Oppenheimer Leland Gershell Downgrade Perform
(Outperform)
N/A
(N/A)
128.86
(113.34)
-12.04% Details
3/11/2021 Stifel Derek Archila New Coverage Buy
(N/A)
190.00
(N/A)
143.99
(113.34)
-21.29% Details
Like ASND Ratings? Also take a look at KALV, EVAX, BIOD, SRRA

ASND Ratings News